Search Results - "BAIREY, O"

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis by Kasenda, B., Ferreri, A.J.M., Marturano, E., Forst, D., Bromberg, J., Ghesquieres, H., Ferlay, C., Blay, J.Y., Hoang-Xuan, K., Pulczynski, E.J., Fosså, A., Okoshi, Y., Chiba, S., Fritsch, K., Omuro, A., O'Neill, B.P., Bairey, O., Schandelmaier, S., Gloy, V., Bhatnagar, N., Haug, S., Rahner, S., Batchelor, T.T., Illerhaus, G., Briel, M.

“…To investigate prognosis and effects of first-line therapy in elderly primary central nervous system lymphoma (PCNSL) patients. A systematic review of studies…”
Get full text

A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA—OUTCOMES INDICATIVE FOR IMPROVED SURVIVAL OVERTIME by Bairey, O., Lebel, E., Buxbaum, C., Porges, T., Taliansky, A., Gurion, R., Goldschmidt, N., Shina, T. Tzuk, Zektser, M., Hofstetter, L., Siegal, T.

Get full text

Primary lymphoma of the female genital tract: a retrospective survey of the International Extranodal Lymphoma Study Group (IELSG35) by Steffanoni, S., Vanazzi, A., Esposito, F., Cabrera, M. E., Akhtar, S. S., Gardella, S., Bairey, O., Pavlovsky, A., Polino, A., Landi, F., Stathis, A., Zucca, E., Pirosa, M. C.

Get full text

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions by Ferreri, Andres J.M, Dognini, Giuseppina P, Campo, Elias, Willemze, Rein, Seymour, John F, Bairey, Osnat, Martelli, Maurizio, De Renzo, Amalia, Doglioni, Claudio, Montalban, Carlos, Tedeschi, Alberto, Pavlovsky, Astrid, Morgan, Sue, Uziel, Lilj, Ferracci, Massimo, Ascani, Stefano, Gianelli, Umberto, Patriarca, Carlo, Facchetti, Fabio, Dalla Libera, Alessio, Pertoldi, Barbara, Horvath, Barbara, Szomor, Arpad, Zucca, Emanuele, Cavalli, Franco, Ponzoni, Maurilio, on behalf of International Extranodal Lymphoma Study Group (IELSG)

“…Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy (AJMF, GPD); Div. of Pathology, Hospital Clínic, Barcelona, Spain (EC); Dutch Cutaneous…”
Get full text

FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2 by Coutre, S. E., Barr, P. M., Owen, C., Robak, T., Tedeschi, A., Bairey, O., Burger, J. A., Hillmen, P., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Dai, S., Szoke, A., Dean, J. P., Kipps, T. J., Ghia, P.

Get full text

Non-Hodgkin's lymphoma in patients 80 years of age or older by Bairey, O., Benjamini, O., Blickstein, D., Elis, A., Ruchlemer, R.

“…Very elderly patients (≥80 years old) with non-Hodgkin's lymphoma (NHL) frequently have co-morbid conditions and are generally excluded from clinical trials or…”
Get full text

FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA by Tedeschi, A., Burger, J., Barr, P.M., Robak, T., Owen, C., Ghia, P., Bairey, O., Hillmen, P., Coutre, S., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Dai, S., Lal, I., Dean, J.P., Kipps, T.J.

Get full text

PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: AN UPDATE WITH DATA FROM 181 PATIENTS by Lammer, F., May, L., Martus, P., Schroers, R., Schlegel, U., Hofer, S., Bairey, O., Schmitz, N., Griesinger, F., Schmidt‐Hieber, M., Weißinger, F., Reimer, P., Coutre, P., Fix, P., Hopfer, O., Junghanß, C., Höffkes, H., Heilmeier, B., Möhle, R., Lange, E., Korfel, A., Keller, U.

Get full text

CURRENT THERAPY OF SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: DATA FROM A MULTICENTER PROSPECTIVE INTERNATIONAL REGISTRY by Korfel, A., Schroers, R., Schlegel, U., Schmitz, N., Hofer, S., Bairey, O., Schmidt‐Hieber, M., Le Coutre, P., Janz, M., Reimer, P., Martus, P.

Get full text

Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells by BAIREY, O., VANICHKIN, A., SHPILBERG, O.

“…Summary Chronic lymphocytic leukemia (CLL) cells are characterized by defective apoptosis which leads to their extended survival. Arsenic trioxide (As2O3) was…”
Get full text

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells by Bairey, O, Boycov, O, Kaganovsky, E, Zimra, Y, Shaklai, M, Rabizadeh, E

“…B-chronic lymphocytic leukemia (B-CLL) cells have a long survival owing to an alteration in the normal pathways of apoptosis. CLL cells have been found to…”
Get full text

Bcl‐2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia by Bairey, O., Zimra, Y., Shaklai, M., Rabizadeh, E.

“…A large proportion of B‐chronic lymphocytic leukaemia (B‐CLL) cells express the anti‐apoptotic protein Bcl‐2. Basic fibroblast growth factor (bFGF) has been…”
Get full text

Serum CA 125 levels in patients with chronic lymphocytic leukemia by BAIREY, O., SHAKLAI, M.

“…Summary Cancer antigen 125 (CA 125) is a glycoprotein expressed in normal tissues originally derived from celomic epithelia and its serum level is elevated in…”
Get full text

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma by PAZGAL, I, ZIMRA, Y, TZABAR, C, OKON, E, RABIZADEH, E, SHAKLAI, M, BAIREY, O

“…It is now clear that angiogenesis and angiogenesis factors are important in the pathogenesis of haematological malignancies. High pretreatment levels of serum…”
Get full text

P11.67.B A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - OUTCOMES INDICATIVE OF IMPROVED SURVIVAL OVER TIME by Bairey, O, Lebe, E, Buxbaum, C, Porges, T, Taliansky, A, Gurion, R, Goldschmidt, N, Tzuk Shina, T, Zektser, M, Hofstetter, L, Siegal, T

Get full text

Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review by Shapira, Y, Bairey, O, Vatury, M, Magen-Nativ, H, Prokocimer, M, Sagie, A

“…Brisk hemolysis due to perivalvular leak is usually an indication for valve re-replacement. Repeated surgery after multiple previous valve operations is…”
Get more information

P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL) by Bairey, O, Amiel, A, Yust-Katz, S, Gurion, R, Siegal, T

“…Abstract BACKGROUND Patients older than 60 years account for up to 70% of all PCNSL cases. Elderly PCNSL patients have median overall survival (OS) under 2…”
Get full text

Doxorubicin and a butyric acid derivative effectively reduce levels of BCL‐2 protein
in the cells of chronic lymphocytic
leukemia patient by Rabizadeh, E., Bairey, O., Aviram, A., Ben‐Dror, I., Shaklai, M., Zimra, Y.

“…: B‐chronic lymphocytic leukemia (B‐CLL) is a disease caused primarily by defects in the apoptosis mechanism. AN‐9, a butyric acid (BA) derivative, is a potent…”
Get full text

Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease by AVIRAM, A, RABIZADEH, E, ZIMRA, Y, YESHORON, M, MARMELSTEIN, M, SHAKLAI, M, BAIREY, O

“…B-Chronic lymphocytic leukemia (B-CLL) is an example of a human malignancy caused by alterations in the pathways of programmed cell death. In this disease the…”
Get full text

Severe Tissue Necrosis After Cisplatin Extravasation at Low Concentration: Possible “Immediate Recall Phenomenon” by Bairey, Osnat, Shaklai, Mati, Bishara, Jihad, Stahl, Bracha

“…Bairey et al explore the prevalence of extravasation of vesicant antineoplastic agents, a serious complication in intravenous chemotherapy…”
Get full text